Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

28,437 signal articles · 181 in last 24h · 139,041 total before filter · latest 13m ago
181last 24h
937last 7d
137● bullish (7d)
117● bearish (7d)
209publishers
AllMacro249Earnings262M&A87Regulatory16Product9Analyst16
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Sunrun (RUN) Stock Fair Value Falls As Analysts Weigh Growth Projects And Cash Risks
Simply Wall St.32d agobearish
Sunrun (RUN) Stock Fair Value Falls As Analysts Weigh Growth Projects And Cash Risks

Sunrun’s latest internal fair value estimate has shifted from US$18.84 to US$17.05, signaling a more conservative stance on the stock’s pricing. This reset lines up with recent Street research that balances enthusiasm for Sunrun’s grid scale storage and AI related projects with concerns about execution, cash generation, and sector level risks. As you read on, you will see how these moving pieces shape the evolving Sunrun narrative and what that can mean for your own view on the stock. Stay...

Hilton Worldwide Holdings (HLT) Could Be 9% Undervalued On Earnings And Buybacks
Simply Wall St.32d agobullish
Hilton Worldwide Holdings (HLT) Could Be 9% Undervalued On Earnings And Buybacks

Earnings, Dividend and Buyback Put Hilton Worldwide Holdings in Focus Hilton Worldwide Holdings (HLT) has drawn investor attention after reporting second quarter 2026 results, reaffirming its regular cash dividend and updating progress on a long running share repurchase program. For the second quarter ended June 30, 2026, Hilton Worldwide Holdings reported revenue of US$3,341 million compared with US$3,137 million a year earlier. Net income was US$482 million, with basic earnings per share...

Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?
Simply Wall St.32d agobullish
Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...

What Do MARA Holdings (MARA) Board Changes And Losses Mean For Its AI Pivot?
Simply Wall St.32d agoneutral
What Do MARA Holdings (MARA) Board Changes And Losses Mean For Its AI Pivot?

MARA Holdings (NasdaqCM:MARA) announced major boardroom changes as it pushes further into AI focused infrastructure and away from a pure bitcoin mining profile. Two directors resigned and were immediately replaced by industry figures with backgrounds in power and hyperscale data centers to support the company’s new direction. The board reshuffle came alongside the release of quarterly results that showed a substantial net loss and plans to expand power availability and AI capacity. These...

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update
Simply Wall St.32d agobullish
Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about US$1.35b, including 11,599,094 shares between April and June 2026. See our latest analysis for Abbott Laboratories. Abbott Laboratories shares trade at US$107.81 and have gained 27.86% over the past 90 days, while the year-to-date share price return is down 13.19% and the 1-year total shareholder return is down 17.86%. This points to...

Cheniere Energy Q2 Earnings Call Highlights
MarketBeat32d agoneutral
Cheniere Energy Q2 Earnings Call Highlights

Cheniere Energy (NYSE:LNG) raised its 2026 financial outlook for a second consecutive quarter, citing higher production, stronger marketing margins and optimization activity as global LNG markets faced supply disruption tied to constrained flows through the Strait of Hormuz. The company reported se

Eli Lilly and Company Q2 Earnings Call Highlights
MarketBeat32d agoneutral
Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly and Company (NYSE:LLY) reported 48% revenue growth in the second quarter of 2026, driven primarily by continued demand for its cardiometabolic medicines MOUNJARO and ZEPBOUND, while raising its full-year revenue and earnings guidance. Chair and CEO Dave Ricks said the company delivered gr

Centrus Energy Q2 Earnings Call Highlights
MarketBeat32d agoneutral
Centrus Energy Q2 Earnings Call Highlights

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Google shutting down a popular feature after 10 years
TheStreet32d agoneutral
Google shutting down a popular feature after 10 years

More than a year after announcing plans to phase it out, Google is finally moving ahead with a major change that will affect millions of consumers. The familiar tool has been part of people's daily routines for years, helping with everything from simple questions and reminders to controlling ...

Bank of America revamps Apple stock price target after earnings
TheStreet32d agoneutral
Bank of America revamps Apple stock price target after earnings

ChatGPT went from generating roughly $10 million a month on Apple's App Store in Jan. 2024 to more than $275 million in July 2026. Apple did not build ChatGPT. It does not train it, run it, or market it. But every time someone subscribes, Apple collects a commission. That dynamic is playing out ...